Lerapolturev (PVSRIPO) in GBM

Clinical trial NCT06177964 · RECRUITING

Trial details

NCT number: NCT06177964
Sponsor: Darell Bigner
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Supratentorial Glioblastoma

Start date: 2024-07-15
Primary completion: 2029-02-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.